Item 1.01. Entry into a Material Definitive Agreement.
On December 5, 2019, Wellesley Bancorp, Inc. a Maryland corporation (the “Company” or “Wellesley”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Cambridge Bancorp (“Cambridge”), Wellesley Bank (“Wellesley Bank”), the Company’s subsidiary bank, and Cambridge Trust Company (“Cambridge Trust”), Cambridge’s subsidiary bank, pursuant to which Cambridge will acquire the Company.
Subject to the terms and conditions of the Merger Agreement, which has been approved by the boards of directors of each party, the Company will merge with and into Cambridge, with Cambridge as the surviving entity, and immediately thereafter, Wellesley Bank will merge with and into Cambridge Trust, with Cambridge Trust as the surviving bank (the “Merger”).
Under the terms of the Merger Agreement, each outstanding share of Company common stock will be converted into the right to receive 0.580 shares of Cambridge’s common stock.
The Merger is subject to customary closing conditions, including the receipt of regulatory approvals and approval by the shareholders of the Company and Cambridge, and is expected to close in the second quarter of 2020. Following the Merger, Thomas Fontaine, currently the President and Chief Executive Officer of the Company, will be employed as Chief Banking Officer of Cambridge Trust. Effective at the closing of the transaction, or at Cambridge’s option, immediately following Cambridge’s 2020 annual meeting of shareholders, Mr. Fontaine and two other members of the current board of directors of Wellesley will be appointed to the board of directors of Cambridge and the board of directors of Cambridge Trust, to serve until the next annual meeting of Cambridge at which time the directors will be nominated forre-election.
Concurrently with entering into the Merger Agreement, Cambridge and the Company entered into Voting Agreements with each of the directors and certain of the executive officers of Cambridge and the Company, respectively, pursuant to which such shareholders agreed to vote their shares of Cambridge or the Company, respectively, in favor of the Merger.
If the Merger is not consummated under specified circumstances, the Company may be required to pay Cambridge a termination fee of approximately $4.1 million.
The Merger Agreement also contains customary representations and warranties that the Company and Cambridge made to each other as of specific dates. The assertions embodied in those representations and warranties were made solely for purposes of the contract between the Company and Cambridge, and may be subject to important qualifications and limitations agreed to by the parties in connection with negotiating its terms. Moreover, the representations and warranties are subject to a contractual standard of materiality that may be different from what may be viewed as material to shareholders, and the representations and warranties may have been used to allocate risk between the Company and Cambridge rather than establishing matters as facts.
The foregoing is not a complete description of the Merger Agreement and is qualified in its entirety by reference to the full text of the Merger Agreement, which is filed as Exhibit 2.1 hereto and is incorporated herein by reference. For additional information, reference is made to the joint press release dated December 5, 2019, which is included as Exhibit 99.1 and is incorporated herein by reference.
Important Additional Information and Where to Find It
In connection with the proposed transaction, Cambridge expects to file with the Securities and Exchange Commission (“SEC”) a registration statement on FormS-4 that will include a joint proxy statement of the Company and Cambridge that also constitutes a prospectus of Cambridge, which joint proxy statement/prospectus will be mailed or otherwise disseminated to the Company’s shareholders and Cambridge’s shareholders when it becomes available. The Company and Cambridge also plan to file other relevant documents with the SEC regarding the proposed transaction.INVESTORS ARE URGED TO READ THE JOINT PROXY STATEMENT/PROSPECTUS AND OTHER RELEVANT DOCUMENTS FILED WITH THE SEC IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. You may obtain a free copy of the joint proxy statement/prospectus (if and when it becomes available) and other relevant documents filed by the Company and Cambridge with the SEC at the SEC’s website at www.sec.gov. Copies of the documents filed by the Company with the SEC will be available free of charge on the Company’s website at www.wellesleybank.com or by directing a request to Wellesley Bancorp, Inc., 100 Worcester Street, Suite 300, Wellesley, MA 02481, attention: Corporate Secretary (781)235-2550. Copies of the documents filed by Cambridge with the SEC will be available free of charge on Cambridge’s website at ir.cambridge.com or by directing a request to Cambridge Bancorp, 1336 Massachusetts Avenue, Cambridge, MA 02138, attention: Corporate Secretary (617)876-5500.
No Offer
This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the U.S. Securities Act of 1933, as amended, and otherwise in accordance with applicable law.